ISG to Evaluate Life Sciences Digital Services

Core Insights - Information Services Group (ISG) has initiated a research study focused on IT service providers and contract research organizations (CROs) in the life sciences sector, emphasizing digital and operational advancements [1][2] - The study aims to assess the adoption of advanced technologies, such as GenAI copilots, in critical life sciences processes, with a comprehensive report scheduled for release in April 2026 [2][5] Digital Transformation in Life Sciences - Enterprises are transitioning from experimentation to full-scale digital transformation, rapidly integrating advanced technologies to enhance processes like protocol design and safety reporting [2][5] - The report will evaluate various service areas including digital clinical development, patient engagement, manufacturing and supply chain, pharmacovigilance, regulatory affairs, and commercial operations [2][4] Evaluation Framework - The research will categorize providers into eight quadrants based on their capabilities in delivering digital services to life sciences enterprises, including Clinical Development, Patient Engagement, Manufacturing and Supply Chain, and more [5][6] - Each quadrant will assess specific criteria such as efficiency in drug development, patient-centric design, and compliance with regulatory standards [5][6] Market Coverage and Analysis - The study will provide geographically focused reports on the global life sciences digital services market, analyzing products and services available worldwide [6] - ISG's research combines empirical data with real-world experiences to guide enterprises in selecting appropriate sourcing partners [8] Company Background - ISG is a global AI-centered technology research and advisory firm, serving over 900 clients, including 75 of the top 100 enterprises worldwide [9] - The firm is recognized for its proprietary market data and expertise in leveraging AI to enhance operational excellence and growth for organizations [9]